Track DiaSorin S.p.A. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

DiaSorin S.p.A. DSRLF · Stock Open DiaSorin S.p.A. in new tab

86.00 USD
P/E
27.13
EPS
3.17
Yield
1.75%
P/B
2.56
ROE
9.16
Beta
0.69
Loading chart...
Key Metrics
Earnings dateNov. 5, 2026
P/E27.13
EPS3.17
Book Value33.57
Price to Book2.56
Debt/Equity68.18
% Insiders57.557%
Growth
Revenue Growth0.03%
Earnings Growth0.07%
Dividend
Dividend Yield1.75%
Annual dividends1.51 USD
Ex-Div. DateMay 19, 2026
Payout47.79%

DCF valuation

Model fair value for DiaSorin S.p.A. (DSRLF)
Result
Sign in to run the valuation for DSRLF.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

DiaSorin S.p.A. Logo DiaSorin S.p.A. Analysis (DSRLF)

Italy Health Care Official Website Stock

Is DiaSorin S.p.A. a good investment? DiaSorin S.p.A. (DSRLF) is currently trading at 86.00 USD.

In terms of valuation, the stock trades at a P/E ratio of 27.13. This valuation is generally in line with the broader market.

Earnings Schedule: DiaSorin S.p.A. is expected to release its next earnings report on Nov. 5, 2026.

For income investors, DiaSorin S.p.A. pays a dividend yield of 1.75%. With a payout ratio of 48%, the dividend appears sustainable.

Investor FAQ

Does DiaSorin S.p.A. pay a dividend?

Yes, it pays an annual dividend of 1.51 USD (1.75% yield).

What asset class is DiaSorin S.p.A.?

DiaSorin S.p.A. is classified as a Stock. You can compare it against 7 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Nov. 5, 2026. The company currently has a trailing EPS of 3.17.

Company Profile

DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.

Exchange Ticker
FRA (Germany) 34D.F
STU (Germany) 34D.SG
VIE (Austria) DIAS.VI
MIL (Italy) DIA.MI
BER (Germany) 34D.BE
DUS (Germany) 34D.DU
PNK (United States) DSRLF
Trades
Dividend Yield
1.75%
Annual Dividends
1.51USD
Next Ex. Div Date
May 19, 2026
Payout Ratio
47.79%
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
▸2027
1.52 USD
May 26, 2027 (estimated) 1.5230
▸2026
1.51 USD
May 20, 2026 1.5083
▸2025
1.35 USD
May 21, 2025 1.3504
▸2024
1.25 USD
May 22, 2024 1.2490
▸2023
1.19 USD
May 24, 2023 1.1886
▸2022
1.12 USD
May 25, 2022 1.1203
▸2021
1.22 USD
May 26, 2021 1.2210
▸2020
1.07 USD
June 17, 2020 1.0706
▸2019
1.01 USD
May 22, 2019 1.0053
▸2018
3.05 USD
Dec. 31, 2018 2.0520
May 23, 2018 1.0003
▸2017
0.90 USD
May 24, 2017 0.8988
▸2016
0.73 USD
May 25, 2016 0.7274
▸2015
0.68 USD
May 20, 2015 0.6813
▸2014
0.75 USD
May 22, 2014 0.7544
▸2013
1.74 USD
May 23, 2013 0.6432
Jan. 3, 2013 1.0973
▸2012
0.59 USD
May 24, 2012 0.5874
▸2011
0.57 USD
June 23, 2011 0.5728
▸2010
0.25 USD
June 24, 2010 0.2477
▸2009
0.17 USD
June 18, 2009 0.1660
▸2008
0.16 USD
July 17, 2008 0.1589
Upcoming Dividends
Name Payment Date Status Amount
DiaSorin S.p.A. May 20, 2026 1.5083 USD
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion